IL37 and hepatocellular carcinoma: Moreover, in the same HCC transplantation model in vivo, inoculating IL-37-transfected TAMs into the recipients resulted in significantly reduced tumour growth compared to mice without IL-37 transfection (45), providing further confirmation of the anti-tumour function of IL-37.